Neumora Therapeutics NMRA
NASDAQ NMRA
$0.47 +0.01 (+1.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Neumora Therapeutics (NMRA) Debt Ratio (2025 - 2026)

Updated

Neumora Therapeutics' (NMRA) Debt Ratio was 0.42 for Q2 2026, up 386.1% from 0.09 a year earlier and up 22.7% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Debt Ratio (2025 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Neumora Therapeutics was 0.29.

  • Per Business Quant data, the three quarters before Q2 2026 came in at 0.34 (Q1 2026), 0.29 (Q4 2025) and 0.11 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Neumora Therapeutics 88.31 Mn -529.65 Mn - 0.42
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.42
Mar 31, 2026 0.34
Dec 31, 2025 0.29
Sep 30, 2025 0.31
Jun 30, 2025 0.09
API Access

Neumora Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NMRA&period=max&api_key=YOUR_API_KEY